Meeting
2018 ASCO Annual Meeting
Assessment and management of bone health in women treated with adjuvant anastrozole in the DATA study.
Authors
Irene Van Hellemond
Maastricht University Medical Centre, Maastricht, Netherlands
Irene Van Hellemond , Carolien H. Smorenburg , Petronella Peer , Astrid Swinkels , Caroline M. Seynaeve , Maurice Van Der Sangen , Judith R. Kroep , Hiltje de Graaf , Aafke H. Honkoop , Frans Erdkamp , Franchette van den Berkmortel , Maaike De Boer , Wilfred de Roos , Sabine C. Linn , Alexander Imholz , Vivianne C. Tjan-Heijnen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
NCT00301457
Citation
J Clin Oncol 36, 2018 (suppl; abstr 534)
DOI
10.1200/JCO.2018.36.15_suppl.534
Abstract #
534
Poster Bd #
26
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Bone health program: A community cancer center's experience.
First Author: Manasa Anipindi
Poster
2017 ASCO Annual Meeting
Anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
First Author: Vivianne C. Tjan-Heijnen
Poster
2013 ASCO Annual Meeting
Clinical experience with exemestane in postmenopausal women at increased risk of breast cancer.
First Author: Mia Sorkin
Poster
2022 ASCO Annual Meeting
Efficacy and safety of initial five years of adjuvant endocrine therapy in postmenopausal hormone receptor-positive breast cancer: A systematic review and network meta-analysis.
First Author: Hao Liao